Oviva is a digital health company that helps people with conditions such as obesity, diabetes and food allergies improve their health with medical nutritional therapy from professional dietitians.
Oviva makes accessing expert nutrition and lifestyle advice on how to improve you and your family's health simple.
Oviva was founded in 2013 by Kai Eberhardt and Manuel Baumann. The company is headquartered in Zürich, Zürich, Switzerland, with offices in France, Germany, United KingdomFrance, Germany, and United Kingdom.
Oviva offers both face to face sessions and remote support for clients from dietitians via a secure smartphone app. Clients can log meals with photos, record activity and weight with trackers, and ask questions.
Oviva offers an “evidence-based” digital solution to stop the progression of and reverse Type 2 diabetes and obesity-related conditions. The company has treated 90,000 patients in the last three years across the U.K., Germany, France, Switzerland and the UAE.
Oviva is backed by MTIP, AlbionVC, F-Prime Capital, Eight Roads Ventures, Earlybird and others. The company raised $21M in a Series B financing on Jan 15, 2020. This brings Oviva's total funding to $34M to date.